Eva Hänssler

Title: Eva Hänssler: Innovator in Nucleic Acid Depletion Technology

Introduction

Eva Hänssler is a prominent inventor based in Leverkusen, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid research. Her innovative work has led to the development of methods that enhance the efficiency of nucleic acid analysis.

Latest Patents

Eva Hänssler holds a patent for a method, lysis solution, and kit for selectively depleting animal nucleic acids in a sample. This invention relates to a method for selectively removing animal nucleic acids from non-animal nucleic acids in a sample containing animal cells and other types of cells, such as microbial and plant cells. The patent emphasizes the use of a specific lysis solution and a silica membrane that serves both as a filtration matrix and an adsorption matrix for nucleic acids.

Career Highlights

Eva is currently associated with Qiagen GmbH, a leading company in the field of molecular biology. Her work at Qiagen has allowed her to focus on developing innovative solutions that address challenges in nucleic acid extraction and analysis.

Collaborations

Throughout her career, Eva has collaborated with notable colleagues, including Johann Kubicek and Thorsten Singer. These collaborations have further enriched her research and contributed to advancements in the field.

Conclusion

Eva Hänssler's contributions to biotechnology, particularly in nucleic acid depletion technology, highlight her role as an influential inventor. Her innovative methods and solutions continue to impact the field positively.